S U MM AR R Y Thirty-eight cases of basal ganglia calcification imaged on computed axial tomography were reviewed. Most cases were felt to represent senescent calcification. The possibility of a vascular aetiology in this group is discussed. A less common group of patients was identified with calcification secondary to abnormalities in calcium metabolism or radiation therapy. Three cases of basal ganglia calcifications were detected in juvenile epileptic patients receiving chronic anticonvulsants. These cases may be related to abnormalities in calcium metabolism and alkaline phosphatase activity. Clinical evidence of basal ganglia abnormality was generally absent demonstrating the preservation of neuronal pathways in most cases.
Bilateral basal ganglia calcification is not an unusual finding both on plain skull x-rays (SXR), and in necropsy specimens.1-3 It has been said that when visible on SXR, basal ganglia calcification is associated with hypoparathyroidism in 70-80% of cases.1 A sporadic idiopathic form and a familial form can occur. Familial disease has been associated with progressive mental deterioration and growth retardation;4 chorea, dementia, and palilalia,5 or dystonia.6 A levodopa-resistant Parkinsonian syndrome also has been described. 7 With the advent of computerised tomography (CT) it has become possible to detect calcifications which are not visible on SXR. Fourteen cases of basal ganglia calcification recently shown by CT had normal SXR.8 None showed evidence of calcium abnormality, or evidence of neurological disease referrable to the calcification.
In an effort to define further the CAT appearance and clinical features of basal ganglia calcification we reviewed the reports of all cranial CAT scans performed at Mount Sinai Hospital since the inception of the scanning unit in 1975.
Methods
Included in the initial study were all cases showing bilateral calcific densities in the basal ganglia or cerebellum. In no case did the presence of oedema, compression, cavitation, or lucency arouse the suspicion of tumour, old calcified haemorrhage, or other pathological conditions known to produce calcification. Cases demonstrating unilateral basal ganglia calcification were included when other processes could be excluded. In fact, we found bilateral basal ganglia calcification invariably to be symmetrical.
After the cases were identified, their clinical records were examined, but no necropsy studies were available.
Results
Forty-two cases of basal ganglia calcification (24 females and 18 males) were identified. As 12000 patients were scanned, this gives an incidence of 3-6 per 1000. Four cases were deleted due to absence of sufficient clinical information. The ages ranged from 10 to 86 years. Two-thirds of the cases occurred after age 60 years.
The globus pallidus was affected solely and bilaterally in 23 of the 38 cases (61%). In four cases (11%) there was unilateral globus pallidus calcification. One case had selective involvement of the caudate nucleus. The remaining cases showed bilateral involvement of the globus pallidus and caudate nucleus which at times included the vermis or dentate nucleus of the cerebellum.
All available laboratory data were reviewed. Detailed laboratory testing was available in 26 patients. Calcium and phosphorous measurements were normal in 23 of these 26 cases. Two of these patients had known idiopathic hypoparathyroidism and one surgical patient had prolonged sepsis with multiple metabolic abnormalities including hypocalcaemia. Alkaline phosphatase measurements were elevated in seven patients. Four of these elevations were explained by bone fractures, sepsis, or youth. There were no distinguishing abnormalities in blood count, multichannel lab screen, or urinalysis in the 26 patients. Four patients in the study were receiving anticonvulsants for a chronic seizure disorder.
The table summarises the clinical findings. The cases generally fitted into either a senescent group, or into a secondarily acquired group. The senescent (or "physiological") group was characterised by the absence of basal ganglia dysfunction, absence of metabolic abnormalities predisposing to calcification, and an age over 60 years. This included all cases in the cerebrovascular disease and dementia groups. The 81-year-old lady with Parkinson's disease had a normal response to levodopa and probably fits into this senescent group as do most of the miscellaneous cases.
The secondary group includes those cases which acquired basal ganglia calcification either secondary to, or enhanced by, a primary disease process. In this group are two following irradiation for tumours, two with hypoparathyroidism, and three with seizure disorders receiving anticonvulsants. Clinical signs of basal ganglia dysfunction were also absent in this group. The post-irradiation cases include a 59-year-old man who received directed radiation for a parasellar tumor ten years prior to 
Discussion
Some degree of calcification can be detected in the globus pallidus and dentate nucleus of the cerebellum in 4C-72% of routine autopsy specimens.2
The calcification consists of hydroxyapatite of a nature similar to that found in bones, teeth and renal calculi enmeshed in a protein rich stroma.9 10 Other elements including zinc, iron and magnesium are present in concentrations paralleling those found in hydroxyapatite, but maganese is elevated.10 Neuronal cell loss and gliosis are usually absent at the site of basal ganglia calcification, but when present may accompany symptomatic basal ganglia dysfunction." In this series of patients the absence of clinical symptoms of basal ganglia disease suggests that no significant destruction of neuronal pathways need occur as a result of the deposition of a calcified matrix.
The specific pathophysiology leading to the development of basal ganglia calcification is unknown. Three interrelated factors are suggested (1) a vascular component (2) a disturbance in calcium metabolism and (3) a disturbance in alkaline phosphatase activity. Theoretically a vascular component is suggested by the early proximity of calcification to arteriolar and capillary walls.' 12 In this series atherosclerosIs and hyaline necrosis is postulated as playing a role in the development of senescent basal ganglia calcification. Thirty-four per cent of our patients had clearly defined cere-Bilateral basal ganglia calcifications visualised on CT scan bral vascular disease and a vascular component may have been involved in many of the patients in the senile dementia group. In addition to these patients the two cases of post irradiation basal ganglia calcification are also felt to be related in part to vascular changes. The predilection of the basal ganglia for calcification may be dependent on the preferential perfusion of grey matter and the high rate of blood flow to the basal ganglia. 13 The well-known occurrence of basal ganglia calcification with hypoparathyroidism identifies a disturbance in calcium metabolism as another important factor. The deposition of calcium may be related in part to a change in vascular permeability related to local calcium concentrations. Experi 
